‘Less Is More’ for Edoxaban in Post-TAVI Anticoagulation: ENVISAGE-TAVI AF -

Although edoxaban was associated with similar net adverse cardiac events as vitamin K antagonists, it was linked to high rates of major bleeding in this phase 3b study.